홈 > 시장보고서 > 의료기기 > 약물전달기기

시장보고서

상품코드

1534575

경장용 시린지 시장 규모, 점유율, 동향 분석 : 연령대별, 최종사용자별, 유형별, 지역별 전망 및 예측(2024-2031년)

Global Enteral Syringe Market Size, Share & Trends Analysis Report By Age Group (Adults and Pediatrics), By End User (Hospitals, Ambulatory Surgical Centers, and Homecare), By Type (Disposable and Reusable), By Regional Outlook and Forecast, 2024 - 2031

발행일: 2024년 08월 | 리서치사:

KBV Research | 페이지 정보: 영문 226 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 경장용 시린지 시장 규모는 예측 기간 동안 5.1%의 CAGR로 성장하여 2031년까지 5억 5,690만 달러에 달할 것으로 예상됩니다.

또한, 노인들은 종종 전문적인 영양 보충이 필요한 건강 상태를 가지고 있는 경우가 많습니다. 영양실조, 연하장애(삼키기 어려움), 만성질환과 같은 증상은 종종 경장영양 솔루션을 필요로 하는 경우가 많습니다. 또한 당뇨병, 심장병, 암과 같은 만성 질환은 노인층에서 많이 발생합니다. 따라서 고령화 인구의 증가가 시장 성장을 주도하고 있습니다.

그러나 의료 시설, 특히 예산 제약이 심한 의료 시설은 고급 주사기에 대한 지출을 정당화하기 위해 고군분투할 수 있습니다. 환자, 특히 저소득층 및 의료 자금이 제한된 지역의 환자는 고급 주사기의 높은 비용으로 인해 고급 주사기에 대한 접근이 제한 될 수 있습니다. 결론적으로 고급 주사기의 높은 비용이 시장 성장을 방해하고 있습니다.

또한, 팬데믹 기간 동안 선택적 의료 절차 및 치료의 연기로 인해 특정 의료 현장에서는 이러한 주사기의 필요성이 감소했으며, COVID-19 위기로 인한 의료 시설에 대한 압도적인 압력으로 인해 장내 영양 공급이 필요한 환자의 일상적인 치료 및 관리가 중단되었습니다. 주요 산업 행사, 박람회 및 컨퍼런스가 취소되거나 가상으로 개최되어 네트워킹 및 시장 성장 기회가 제한되었습니다. 이처럼 COVID-19는 시장에 부정적인 영향을 미쳤습니다.

연령대 전망

연령대별로 시장은 성인과 소아로 나뉘며, 2023년에는 소아 부문이 시장 매출 점유율의 23%를 차지했습니다. 의학의 발전으로 조산아 및 심각한 건강 상태를 가진 어린이의 생존율이 크게 향상되었으며, 이들 중 상당수는 경장영양이 필요합니다.

북미
- 북미의 경장용 시린지 시장 : 국가별
  - 미국
  - 캐나다
  - 멕시코
  - 기타 북미
유럽
- 유럽의 경장용 시린지 시장 : 국가별
  - 독일
  - 영국
  - 프랑스
  - 러시아
  - 스페인
  - 이탈리아
  - 기타 유럽
아시아태평양
- 아시아태평양의 경장용 시린지 시장 : 국가별
  - 중국
  - 일본
  - 인도
  - 한국
  - 싱가포르
  - 말레이시아
  - 기타 아시아태평양
라틴아메리카, 중동 및 아프리카
- 라틴아메리카, 중동 및 아프리카의 경장용 시린지 시장 : 국가별
  - 브라질
  - 아르헨티나
  - 아랍에미리트
  - 사우디아라비아
  - 남아프리카공화국
  - 나이지리아
  - 기타 라틴아메리카, 중동 및 아프리카

제8장 기업 개요

Boston Scientific Corporation
Nestle SA
Fresenius SE & Co KGaA
Becton, Dickinson, and Company
B Braun Melsungen AG
Cardinal Health, Inc
Moog, Inc
Cook Medical, Inc(Cook Group)
Thermo Fisher Scientific, Inc
Medela AG

제9장 경장용 시린지 시장의 성공 필수 조건

ksm 24.08.28

The Global Enteral Syringe Market size is expected to reach $556.9 million by 2031, rising at a market growth of 5.1% CAGR during the forecast period.

The prevalence of chronic diseases, such as cancer and cardiovascular conditions, is on the rise in the Asia-Pacific region. These conditions often require enteral feeding, increasing the demand for these syringes. Patients with chronic illnesses may need long-term nutritional support, which can be effectively managed using these syringes. Consequently, the Asia Pacific region would acquire nearly 30% of the total market share by 2031.

Adopting nutritional support therapy emphasizes personalized care tailored to individual patient needs. In addition, updated clinical guidelines and protocols now commonly include recommendations for nutritional support therapy as a standard practice for managing patients with specific health conditions. Hence, the increasing adoption of nutritional support therapy is driving the market's growth.

Additionally, Older adults frequently experience health conditions that necessitate specialized nutritional support. Conditions such as malnutrition, dysphagia (difficulty swallowing), and chronic illnesses often require enteral feeding solutions. Additionally, chronic diseases like diabetes, heart disease, and cancer are more common among the elderly population. Thus, the growing aging population is propelling the growth of the market.

However, Healthcare facilities, particularly those operating under tight budget constraints, may struggle to justify the expenditure on advanced syringes. Patients, especially those in lower-income brackets or regions with limited healthcare funding, may have restricted access to advanced syringes due to their high cost. In conclusion, the high cost of advanced syringes hampers the market's growth.

Moreover, the postponement of elective medical procedures and treatments during the pandemic decreased the need for these syringes in certain healthcare settings. The overwhelming pressure on healthcare facilities due to the COVID-19 crisis disrupted routine care and management of patients requiring enteral feeding. Major industry events, trade shows, and conferences were cancelled or held virtually, limiting networking and market growth opportunities. Thus, the COVID-19 had a negative impact on the market.

Age Group Outlook

On the basis of age group, the market is segmented into adults and paediatrics. In 2023, the paediatrics segment attained 23% revenue share in the market. Advances in medical care have significantly improved the survival rates of preterm infants and children with severe health conditions, many of whom require enteral feeding.

End User Outlook

By end user, the market is divided into hospitals, ambulatory surgical centres, and homecare. The homecare segment procured a 13% revenue share in the market in 2023. As the global population ages, more elderly individuals require long-term care, including enteral feeding, which can be effectively managed at home using these syringes.

Type Outlook

Based on type, the market is divided into reusable and disposable. The reusable segment procured 37% revenue share in the market in 2023. Although reusable syringes require an initial investment, they can be more cost-effective over time than disposable syringes. For healthcare facilities with high usage rates, the cumulative cost of disposables can be significantly higher.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed a 35% revenue share in the market in 2022. North America boasts a sophisticated healthcare system with numerous hospitals, clinics, and long-term care facilities equipped with advanced medical technologies, including these syringes.

List of Key Companies Profiled

Boston Scientific Corporation
Nestle S.A.
Fresenius SE & Co. KGaA
Becton, Dickinson and Company
B. Braun Melsungen AG
Cardinal Health, Inc.
Moog Inc.
Cook Medical, Inc.(Cook Group)
Thermo Fisher Scientific Inc.
Medela AG

Global Enteral Syringe Market Report Segmentation

By Age Group

Adults
Pediatrics

By End User

Hospitals
Ambulatory Surgical Centers
Homecare

By Type

Disposable
Reusable

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Enteral Syringe Market, by Age Group
- 1.4.2 Global Enteral Syringe Market, by End User
- 1.4.3 Global Enteral Syringe Market, by Type
- 1.4.4 Global Enteral Syringe Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Global Enteral Syringe Market by Age Group

4.1 Global Adults Market by Region
4.2 Global Pediatrics Market by Region

Chapter 5. Global Enteral Syringe Market by End User

5.1 Global Hospitals Market by Region
5.2 Global Ambulatory Surgical Centers Market by Region
5.3 Global Homecare Market by Region

Chapter 6. Global Enteral Syringe Market by Type

6.1 Global Disposable Market by Region
6.2 Global Reusable Market by Region

Chapter 7. Global Enteral Syringe Market by Region

7.1 North America Enteral Syringe Market
- 7.1.1 North America Enteral Syringe Market by Age Group
  - 7.1.1.1 North America Adults Market by Region
  - 7.1.1.2 North America Pediatrics Market by Region
- 7.1.2 North America Enteral Syringe Market by End User
  - 7.1.2.1 North America Hospitals Market by Country
  - 7.1.2.2 North America Ambulatory Surgical Centers Market by Country
  - 7.1.2.3 North America Homecare Market by Country
- 7.1.3 North America Enteral Syringe Market by Type
  - 7.1.3.1 North America Disposable Market by Country
  - 7.1.3.2 North America Reusable Market by Country
- 7.1.4 North America Enteral Syringe Market by Country
  - 7.1.4.1 US Enteral Syringe Market
    - 7.1.4.1.1 US Enteral Syringe Market by Age Group
    - 7.1.4.1.2 US Enteral Syringe Market by End User
    - 7.1.4.1.3 US Enteral Syringe Market by Type
  - 7.1.4.2 Canada Enteral Syringe Market
    - 7.1.4.2.1 Canada Enteral Syringe Market by Age Group
    - 7.1.4.2.2 Canada Enteral Syringe Market by End User
    - 7.1.4.2.3 Canada Enteral Syringe Market by Type
  - 7.1.4.3 Mexico Enteral Syringe Market
    - 7.1.4.3.1 Mexico Enteral Syringe Market by Age Group
    - 7.1.4.3.2 Mexico Enteral Syringe Market by End User
    - 7.1.4.3.3 Mexico Enteral Syringe Market by Type
  - 7.1.4.4 Rest of North America Enteral Syringe Market
    - 7.1.4.4.1 Rest of North America Enteral Syringe Market by Age Group
    - 7.1.4.4.2 Rest of North America Enteral Syringe Market by End User
    - 7.1.4.4.3 Rest of North America Enteral Syringe Market by Type
7.2 Europe Enteral Syringe Market
- 7.2.1 Europe Enteral Syringe Market by Age Group
  - 7.2.1.1 Europe Adults Market by Country
  - 7.2.1.2 Europe Pediatrics Market by Country
- 7.2.2 Europe Enteral Syringe Market by End User
  - 7.2.2.1 Europe Hospitals Market by Country
  - 7.2.2.2 Europe Ambulatory Surgical Centers Market by Country
  - 7.2.2.3 Europe Homecare Market by Country
- 7.2.3 Europe Enteral Syringe Market by Type
  - 7.2.3.1 Europe Disposable Market by Country
  - 7.2.3.2 Europe Reusable Market by Country
- 7.2.4 Europe Enteral Syringe Market by Country
  - 7.2.4.1 Germany Enteral Syringe Market
    - 7.2.4.1.1 Germany Enteral Syringe Market by Age Group
    - 7.2.4.1.2 Germany Enteral Syringe Market by End User
    - 7.2.4.1.3 Germany Enteral Syringe Market by Type
  - 7.2.4.2 UK Enteral Syringe Market
    - 7.2.4.2.1 UK Enteral Syringe Market by Age Group
    - 7.2.4.2.2 UK Enteral Syringe Market by End User
    - 7.2.4.2.3 UK Enteral Syringe Market by Type
  - 7.2.4.3 France Enteral Syringe Market
    - 7.2.4.3.1 France Enteral Syringe Market by Age Group
    - 7.2.4.3.2 France Enteral Syringe Market by End User
    - 7.2.4.3.3 France Enteral Syringe Market by Type
  - 7.2.4.4 Russia Enteral Syringe Market
    - 7.2.4.4.1 Russia Enteral Syringe Market by Age Group
    - 7.2.4.4.2 Russia Enteral Syringe Market by End User
    - 7.2.4.4.3 Russia Enteral Syringe Market by Type
  - 7.2.4.5 Spain Enteral Syringe Market
    - 7.2.4.5.1 Spain Enteral Syringe Market by Age Group
    - 7.2.4.5.2 Spain Enteral Syringe Market by End User
    - 7.2.4.5.3 Spain Enteral Syringe Market by Type
  - 7.2.4.6 Italy Enteral Syringe Market
    - 7.2.4.6.1 Italy Enteral Syringe Market by Age Group
    - 7.2.4.6.2 Italy Enteral Syringe Market by End User
    - 7.2.4.6.3 Italy Enteral Syringe Market by Type
  - 7.2.4.7 Rest of Europe Enteral Syringe Market
    - 7.2.4.7.1 Rest of Europe Enteral Syringe Market by Age Group
    - 7.2.4.7.2 Rest of Europe Enteral Syringe Market by End User
    - 7.2.4.7.3 Rest of Europe Enteral Syringe Market by Type
7.3 Asia Pacific Enteral Syringe Market
- 7.3.1 Asia Pacific Enteral Syringe Market by Age Group
  - 7.3.1.1 Asia Pacific Adults Market by Country
  - 7.3.1.2 Asia Pacific Pediatrics Market by Country
- 7.3.2 Asia Pacific Enteral Syringe Market by End User
  - 7.3.2.1 Asia Pacific Hospitals Market by Country
  - 7.3.2.2 Asia Pacific Ambulatory Surgical Centers Market by Country
  - 7.3.2.3 Asia Pacific Homecare Market by Country
- 7.3.3 Asia Pacific Enteral Syringe Market by Type
  - 7.3.3.1 Asia Pacific Disposable Market by Country
  - 7.3.3.2 Asia Pacific Reusable Market by Country
- 7.3.4 Asia Pacific Enteral Syringe Market by Country
  - 7.3.4.1 China Enteral Syringe Market
    - 7.3.4.1.1 China Enteral Syringe Market by Age Group
    - 7.3.4.1.2 China Enteral Syringe Market by End User
    - 7.3.4.1.3 China Enteral Syringe Market by Type
  - 7.3.4.2 Japan Enteral Syringe Market
    - 7.3.4.2.1 Japan Enteral Syringe Market by Age Group
    - 7.3.4.2.2 Japan Enteral Syringe Market by End User
    - 7.3.4.2.3 Japan Enteral Syringe Market by Type
  - 7.3.4.3 India Enteral Syringe Market
    - 7.3.4.3.1 India Enteral Syringe Market by Age Group
    - 7.3.4.3.2 India Enteral Syringe Market by End User
    - 7.3.4.3.3 India Enteral Syringe Market by Type
  - 7.3.4.4 South Korea Enteral Syringe Market
    - 7.3.4.4.1 South Korea Enteral Syringe Market by Age Group
    - 7.3.4.4.2 South Korea Enteral Syringe Market by End User
    - 7.3.4.4.3 South Korea Enteral Syringe Market by Type
  - 7.3.4.5 Singapore Enteral Syringe Market
    - 7.3.4.5.1 Singapore Enteral Syringe Market by Age Group
    - 7.3.4.5.2 Singapore Enteral Syringe Market by End User
    - 7.3.4.5.3 Singapore Enteral Syringe Market by Type
  - 7.3.4.6 Malaysia Enteral Syringe Market
    - 7.3.4.6.1 Malaysia Enteral Syringe Market by Age Group
    - 7.3.4.6.2 Malaysia Enteral Syringe Market by End User
    - 7.3.4.6.3 Malaysia Enteral Syringe Market by Type
  - 7.3.4.7 Rest of Asia Pacific Enteral Syringe Market
    - 7.3.4.7.1 Rest of Asia Pacific Enteral Syringe Market by Age Group
    - 7.3.4.7.2 Rest of Asia Pacific Enteral Syringe Market by End User
    - 7.3.4.7.3 Rest of Asia Pacific Enteral Syringe Market by Type
7.4 LAMEA Enteral Syringe Market
- 7.4.1 LAMEA Enteral Syringe Market by Age Group
  - 7.4.1.1 LAMEA Adults Market by Country
  - 7.4.1.2 LAMEA Pediatrics Market by Country
- 7.4.2 LAMEA Enteral Syringe Market by End User
  - 7.4.2.1 LAMEA Hospitals Market by Country
  - 7.4.2.2 LAMEA Ambulatory Surgical Centers Market by Country
  - 7.4.2.3 LAMEA Homecare Market by Country
- 7.4.3 LAMEA Enteral Syringe Market by Type
  - 7.4.3.1 LAMEA Disposable Market by Country
  - 7.4.3.2 LAMEA Reusable Market by Country
- 7.4.4 LAMEA Enteral Syringe Market by Country
  - 7.4.4.1 Brazil Enteral Syringe Market
    - 7.4.4.1.1 Brazil Enteral Syringe Market by Age Group
    - 7.4.4.1.2 Brazil Enteral Syringe Market by End User
    - 7.4.4.1.3 Brazil Enteral Syringe Market by Type
  - 7.4.4.2 Argentina Enteral Syringe Market
    - 7.4.4.2.1 Argentina Enteral Syringe Market by Age Group
    - 7.4.4.2.2 Argentina Enteral Syringe Market by End User
    - 7.4.4.2.3 Argentina Enteral Syringe Market by Type
  - 7.4.4.3 UAE Enteral Syringe Market
    - 7.4.4.3.1 UAE Enteral Syringe Market by Age Group
    - 7.4.4.3.2 UAE Enteral Syringe Market by End User
    - 7.4.4.3.3 UAE Enteral Syringe Market by Type
  - 7.4.4.4 Saudi Arabia Enteral Syringe Market
    - 7.4.4.4.1 Saudi Arabia Enteral Syringe Market by Age Group
    - 7.4.4.4.2 Saudi Arabia Enteral Syringe Market by End User
    - 7.4.4.4.3 Saudi Arabia Enteral Syringe Market by Type
  - 7.4.4.5 South Africa Enteral Syringe Market
    - 7.4.4.5.1 South Africa Enteral Syringe Market by Age Group
    - 7.4.4.5.2 South Africa Enteral Syringe Market by End User
    - 7.4.4.5.3 South Africa Enteral Syringe Market by Type
  - 7.4.4.6 Nigeria Enteral Syringe Market
    - 7.4.4.6.1 Nigeria Enteral Syringe Market by Age Group
    - 7.4.4.6.2 Nigeria Enteral Syringe Market by End User
    - 7.4.4.6.3 Nigeria Enteral Syringe Market by Type
  - 7.4.4.7 Rest of LAMEA Enteral Syringe Market
    - 7.4.4.7.1 Rest of LAMEA Enteral Syringe Market by Age Group
    - 7.4.4.7.2 Rest of LAMEA Enteral Syringe Market by End User
    - 7.4.4.7.3 Rest of LAMEA Enteral Syringe Market by Type

Chapter 8. Company Profiles

8.1 Boston Scientific Corporation
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 Nestle S.A.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 SWOT Analysis
8.3 Fresenius SE & Co. KGaA
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
8.4 Becton, Dickinson, and Company
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 SWOT Analysis
8.5 B. Braun Melsungen AG
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 SWOT Analysis
8.6 Cardinal Health, Inc.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 SWOT Analysis
8.7 Moog, Inc.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
8.8 Cook Medical, Inc. (Cook Group)
- 8.8.1 Company Overview
- 8.8.2 SWOT Analysis
8.9 Thermo Fisher Scientific, Inc.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expenses
- 8.9.5 SWOT Analysis
8.10. Medela AG
- 8.10.1 Company Overview
- 8.10.2 SWOT Analysis

Chapter 9. Winning Imperatives for Enteral Syringe Market

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 3,600

￦ 5,341,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320

￦ 6,409,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048

￦ 8,973,000

※ 부가세 별도

경장용 시린지 시장 규모, 점유율, 동향 분석 : 연령대별, 최종사용자별, 유형별, 지역별 전망 및 예측(2024-2031년)

Global Enteral Syringe Market Size, Share & Trends Analysis Report By Age Group (Adults and Pediatrics), By End User (Hospitals, Ambulatory Surgical Centers, and Homecare), By Type (Disposable and Reusable), By Regional Outlook and Forecast, 2024 - 2031

목차

제1장 시장 범위와 조사 방법

제2장 시장 요람

제3장 시장 개요

제4장 세계의 경장용 시린지 시장 : 연령층별

제5장 세계의 경장용 시린지 시장 : 최종사용자별

제6장 세계의 경장용 시린지 시장 : 유형별

제7장 세계의 경장용 시린지 시장 : 지역별